Elahe Akbarian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elahe Akbarian has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Mehran Karimi
Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
7 shared publications - Zahra Nafei
Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publications - Alireza Emarati
Shahid Sadoughi University of Medical Sciences
3 shared publications - Farimah Shamsi
Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 shared publications Alireza Emarati
Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 shared publications- Nasrin Behniafard
Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published byĀ Springer NatureĀ inĀ Scientific Reports
Prenatal, perinatal, and neonatal factors associated with attention-deficit/hyperactivity disorder: a case-control study in Iranian children and adolescents
- 14 November 2026
- Published byĀ Springer NatureĀ inĀ Scientific Reports
Open AccessPrenatal, perinatal, and neonatal factors associated with attention-deficit/hyperactivity disorder: a case-control study in Iranian children and adolescents
- Open Access
- 10 August 2026
- Published byĀ SAGE PublicationsĀ inĀ Global Spine Journal
Comments on āMental Health Problems in Traumatic Spinal Cord Injury Patients - An Umbrella Systematic Reviewā
- 10 August 2026
- Published byĀ SAGE PublicationsĀ inĀ Global Spine Journal
Open AccessComments on āMental Health Problems in Traumatic Spinal Cord Injury Patients - An Umbrella Systematic Reviewā
- Top Cited PapersOpen Access
- 31 March 2026
- Published byĀ Springer NatureĀ inĀ Egyptian Pediatric Association Gazette
- Vol.Ā 74 Ā (1) , 36
Artificial intelligence in ADHD diagnosis: a comprehensive review of machine learning applications, clinical validation challenges, and implementation barriers in precision medicine
Background: Attention Deficit Hyperactivity Disorder (ADHD) affects approximately 7.2% of the global population, representing one of the most prevalent neurodevelopmental disorders. While current clinical diagnostic approaches, including validated instruments such as the SNAP-IV, Conners-4, and ADHD-RS, enable trained clinicians to reach reliable diagnoses in most cases, certain clinical scenarios remain challenging, including borderline presentations, complex comorbidity patterns, and settings with limited access to specialist clinicians. The absence of objective biomarkers meeting established clinical criteria has motivated exploration of computational approaches as potential augmentative diagnostic tools. Methods: This comprehensive narrative review analyzes machine learning (ML) and deep learning (DL) applications across the ADHD clinical pathway, encompassing objective diagnosis, subtype differentiation, prediction of treatment response, digital therapeutic interventions, and long-term outcome prognostication. PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, and Google Scholar were searched from inception through September 2025 across multiple modalities including electroencephalography (EEG), neuroimaging, wearable technology, virtual reality, eye-tracking, genomics, digital therapeutics, and multimodal integration approaches. Diagnostic performance, clinical validation, model interpretability, class imbalance considerations, and translational potential were evaluated while identifying critical gaps requiring additional research. Results: EEG-based classification demonstrates the most consistent high performance, with recent studies achieving accuracies exceeding 99% using advanced CNN and transformer architectures; however, these results are typically obtained from small, single-site datasets and should be interpreted with caution. Wearable technology shows significant promise with 89% accuracy in large-scale validation ( n = 450; AUC = 0.95), while virtual reality assessments achieve clinically relevant performance (AUC = 0.893). Eye-tracking technology achieves exceptional diagnostic performance (AUC = 0.965, accuracy = 90.8%), and genomic approaches utilizing advanced polygenic risk scores achieve meaningful performance (AUC = 0.72). Multimodal integration approaches demonstrate superior diagnostic accuracy compared to single-modality assessments. Importantly, well-validated studies employing rigorous multi-site validation typically report realistic performance in the range of 70ā85%, and metrics such as ROC-AUC, sensitivity, specificity, and positive predictive value (PPV) provide more clinically meaningful evaluations than overall accuracy alone, particularly given the class imbalance inherent in ADHD prevalence (5ā10%). Conclusions: While ML/DL technologies show considerable promise for augmenting objective ADHD assessment, including diagnosis, treatment response prediction, and long-term outcome prognostication, realistic clinical performance typically ranges from 70 to 85% for well-validated studies. The field requires addressing critical challenges including methodological rigor, clinical validation standards, appropriate handling of class imbalance, gold-standard diagnostic validation, algorithmic interpretability, privacy-preserving techniques, and regulatory frameworks to achieve successful clinical translation. Clinical trial number: Not applicable
- 31 March 2026
- Published byĀ Springer NatureĀ inĀ Egyptian Pediatric Association Gazette
- Vol.Ā 74 Ā (1) , 36
Top Cited PapersOpen AccessArtificial intelligence in ADHD diagnosis: a comprehensive review of machine learning applications, clinical validation challenges, and implementation barriers in precision medicine
Background: Attention Deficit Hyperactivity Disorder (ADHD) affects approximately 7.2% of the global population, representing one of the most prevalent neurodevelopmental disorders. While current clinical diagnostic approaches, including validated instruments such as the SNAP-IV, Conners-4, and ADHD-RS, enable trained clinicians to reach reliable diagnoses in most cases, certain clinical scenarios remain challenging, including borderline presentations, complex comorbidity patterns, and settings with limited access to specialist clinicians. The absence of objective biomarkers meeting established clinical criteria has motivated exploration of computational approaches as potential augmentative diagnostic tools. Methods: This comprehensive narrative review analyzes machine learning (ML) and deep learning (DL) applications across the ADHD clinical pathway, encompassing objective diagnosis, subtype differentiation, prediction of treatment response, digital therapeutic interventions, and long-term outcome prognostication. PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, and Google Scholar were searched from inception through September 2025 across multiple modalities including electroencephalography (EEG), neuroimaging, wearable technology, virtual reality, eye-tracking, genomics, digital therapeutics, and multimodal integration approaches. Diagnostic performance, clinical validation, model interpretability, class imbalance considerations, and translational potential were evaluated while identifying critical gaps requiring additional research. Results: EEG-based classification demonstrates the most consistent high performance, with recent studies achieving accuracies exceeding 99% using advanced CNN and transformer architectures; however, these results are typically obtained from small, single-site datasets and should be interpreted with caution. Wearable technology shows significant promise with 89% accuracy in large-scale validation ( n = 450; AUC = 0.95), while virtual reality assessments achieve clinically relevant performance (AUC = 0.893). Eye-tracking technology achieves exceptional diagnostic performance (AUC = 0.965, accuracy = 90.8%), and genomic approaches utilizing advanced polygenic risk scores achieve meaningful performance (AUC = 0.72). Multimodal integration approaches demonstrate superior diagnostic accuracy compared to single-modality assessments. Importantly, well-validated studies employing rigorous multi-site validation typically report realistic performance in the range of 70ā85%, and metrics such as ROC-AUC, sensitivity, specificity, and positive predictive value (PPV) provide more clinically meaningful evaluations than overall accuracy alone, particularly given the class imbalance inherent in ADHD prevalence (5ā10%). Conclusions: While ML/DL technologies show considerable promise for augmenting objective ADHD assessment, including diagnosis, treatment response prediction, and long-term outcome prognostication, realistic clinical performance typically ranges from 70 to 85% for well-validated studies. The field requires addressing critical challenges including methodological rigor, clinical validation standards, appropriate handling of class imbalance, gold-standard diagnostic validation, algorithmic interpretability, privacy-preserving techniques, and regulatory frameworks to achieve successful clinical translation. Clinical trial number: Not applicable
- Open Access
- 1 March 2025
- Published byĀ Springer NatureĀ inĀ BMC Pediatrics
- Vol.Ā 25 Ā (1) , 1-17
Unveiling developmental delays in early childhood: insights from a comparative study of the Bayley Scales (BSID-III) and the ASQ-3 in Iran
Developmental delay in early childhood is a significant concern with multifaceted causes and implications. The Bayley Scales of Infant and Toddler Development (BSID-III) is widely used for developmental assessment, but its use in Iranian children has been understudied. This study aimed to evaluate the developmental delays of Iranian children aged 1 to 42 months, investigate the association between parental education and these developmental outcomes, and compare developmental outcomes between the BSID-III and the Ages and Stages Questionnaire, Third Edition (ASQ-3). These findings contribute to informing clinical practices, policy makers, and early intervention programs aimed at promoting optimal development for all children. In this cross-sectional study, 707 Iranian children from Yazd, Iran, with suspected developmental delays were recruited from two health centers. Trained examiners administered the Persian-adapted and validated version of the BSID-III following standardized procedures. We hypothesized differences in BSID-III scores compared to normative samples, considering age, gender, and parental education. Additionally, comparisons between BSID-III scores and the validated Iranian version of ASQ-3 outcomes were explored to gain further insights. The study sample exhibited varying rates of developmental delays across Cognitive (15.8%), Receptive Communication (20.1%), Expressive Communication (18.4%), Fine Motor (13.6%) and Gross Motor (15.7%) domains. Additionally, Age-related differences were observed, particularly in Receptive and Expressive Communication, where older children showed higher rates of delays. Gender differences were also significant in the Language Scale, with females showing slightly higher rates of normal development. Moreover, parental education emerged as a significant factor, with higher levels associated with a reduced occurrence of developmental delays. Furthermore, comparisons between BSID-III results and ASQ-3 outcomes highlighted discrepancies, suggesting an imperfect alignment between measures. The analysis demonstrated fair agreement for Cognitive-Problem Solving and Gross Motor development, but poor agreement for Fine Motor development, highlighting the complexity of developmental assessment and the need for cautious interpretation of test results. This study enhances our understanding of developmental assessment in Iranian children with suspected delays by emphasizing culturally sensitive adaptations for assessment tools alongside recognizing how parental education influences developmental trajectories. Future research with diverse, longitudinal samples is warranted to gain a more comprehensive picture.
- 1 March 2025
- Published byĀ Springer NatureĀ inĀ BMC Pediatrics
- Vol.Ā 25 Ā (1) , 1-17
Open AccessUnveiling developmental delays in early childhood: insights from a comparative study of the Bayley Scales (BSID-III) and the ASQ-3 in Iran
Developmental delay in early childhood is a significant concern with multifaceted causes and implications. The Bayley Scales of Infant and Toddler Development (BSID-III) is widely used for developmental assessment, but its use in Iranian children has been understudied. This study aimed to evaluate the developmental delays of Iranian children aged 1 to 42 months, investigate the association between parental education and these developmental outcomes, and compare developmental outcomes between the BSID-III and the Ages and Stages Questionnaire, Third Edition (ASQ-3). These findings contribute to informing clinical practices, policy makers, and early intervention programs aimed at promoting optimal development for all children. In this cross-sectional study, 707 Iranian children from Yazd, Iran, with suspected developmental delays were recruited from two health centers. Trained examiners administered the Persian-adapted and validated version of the BSID-III following standardized procedures. We hypothesized differences in BSID-III scores compared to normative samples, considering age, gender, and parental education. Additionally, comparisons between BSID-III scores and the validated Iranian version of ASQ-3 outcomes were explored to gain further insights. The study sample exhibited varying rates of developmental delays across Cognitive (15.8%), Receptive Communication (20.1%), Expressive Communication (18.4%), Fine Motor (13.6%) and Gross Motor (15.7%) domains. Additionally, Age-related differences were observed, particularly in Receptive and Expressive Communication, where older children showed higher rates of delays. Gender differences were also significant in the Language Scale, with females showing slightly higher rates of normal development. Moreover, parental education emerged as a significant factor, with higher levels associated with a reduced occurrence of developmental delays. Furthermore, comparisons between BSID-III results and ASQ-3 outcomes highlighted discrepancies, suggesting an imperfect alignment between measures. The analysis demonstrated fair agreement for Cognitive-Problem Solving and Gross Motor development, but poor agreement for Fine Motor development, highlighting the complexity of developmental assessment and the need for cautious interpretation of test results. This study enhances our understanding of developmental assessment in Iranian children with suspected delays by emphasizing culturally sensitive adaptations for assessment tools alongside recognizing how parental education influences developmental trajectories. Future research with diverse, longitudinal samples is warranted to gain a more comprehensive picture.
- Open Access
- 17 November 2023
- Published byĀ Springer NatureĀ inĀ Research Square
Assessing Developmental Delays in Early Childhood: Insights from Iranian Children Using the Bayley Scales of Infant and Toddler Development (BSID-III)
Background Developmental delay in early childhood is a significant concern with multifaceted causes and implications. The Bayley Scales of Infant and Toddler Development (BSID-III) is widely used for developmental assessment but remains understudied in Iranian children. Methods This cross-sectional study assessed 707 Iranian children aged 1 to 42 months in Yazd, Iran, using the BSID-III. We hypothesized differences in BSID-III scores compared to normative samples, considering age, gender, and parental education. Data were collected from two health centers in Yazd, with trained examiners following standardized procedures. Parental education was analyzed for its impact on developmental outcomes. Comparisons between BSID-III scores and Ages and Stages Questionnaire (ASQ) outcomes provided additional insights. Results Iranian children exhibited varying rates of developmental disorders across cognitive, language, and motor domains, influenced by parental education (higher parental education correlated with a reduced occurrence of developmental disorders). For instance, in the cognitive domain, 15.8% of children demonstrated developmental disorders. The language scale exhibited varying rates: 20.1% for perceptual communication and 18.4% for expressive communication. Furthermore, the BSID-III and ASQ results demonstrated discordances, highlighting the complexities of assessment. Conclusions This study contributes to the knowledge of developmental assessment in Iranian early childhood. It emphasizes the importance of culturally sensitive adaptations of assessment tools and the role of parental education in shaping developmental outcomes. Future research should incorporate diverse, longitudinal samples for enhanced understanding. Ultimately, this study aims to inform clinical practices, policy development, and early intervention programs, committed to fostering optimal development for all children, irrespective of their backgrounds.
- 17 November 2023
- Published byĀ Springer NatureĀ inĀ Research Square
Open AccessAssessing Developmental Delays in Early Childhood: Insights from Iranian Children Using the Bayley Scales of Infant and Toddler Development (BSID-III)
Background Developmental delay in early childhood is a significant concern with multifaceted causes and implications. The Bayley Scales of Infant and Toddler Development (BSID-III) is widely used for developmental assessment but remains understudied in Iranian children. Methods This cross-sectional study assessed 707 Iranian children aged 1 to 42 months in Yazd, Iran, using the BSID-III. We hypothesized differences in BSID-III scores compared to normative samples, considering age, gender, and parental education. Data were collected from two health centers in Yazd, with trained examiners following standardized procedures. Parental education was analyzed for its impact on developmental outcomes. Comparisons between BSID-III scores and Ages and Stages Questionnaire (ASQ) outcomes provided additional insights. Results Iranian children exhibited varying rates of developmental disorders across cognitive, language, and motor domains, influenced by parental education (higher parental education correlated with a reduced occurrence of developmental disorders). For instance, in the cognitive domain, 15.8% of children demonstrated developmental disorders. The language scale exhibited varying rates: 20.1% for perceptual communication and 18.4% for expressive communication. Furthermore, the BSID-III and ASQ results demonstrated discordances, highlighting the complexities of assessment. Conclusions This study contributes to the knowledge of developmental assessment in Iranian early childhood. It emphasizes the importance of culturally sensitive adaptations of assessment tools and the role of parental education in shaping developmental outcomes. Future research should incorporate diverse, longitudinal samples for enhanced understanding. Ultimately, this study aims to inform clinical practices, policy development, and early intervention programs, committed to fostering optimal development for all children, irrespective of their backgrounds.
- Open Access
- 3 April 2023
- Published byĀ BrieflandsĀ inĀ International Journal of Endocrinology and Metabolism
- Vol.Ā 21 Ā (2) , e132809
Diabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study
Background: Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives: This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods: This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results: The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions: A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.
- 3 April 2023
- Published byĀ BrieflandsĀ inĀ International Journal of Endocrinology and Metabolism
- Vol.Ā 21 Ā (2) , e132809
Open AccessDiabetic Ketoacidosis in Children Before and During COVID-19 Pandemic: A Cross-sectional Study
Background: Coronavirus disease 2019 (COVID-19) has spread quickly. Comorbidities, such as diabetes, have been determined as critical risk factors for COVID-19. Objectives: This study aimed to determine the frequency and severity of diabetic ketoacidosis (DKA) in children before and during the COVID-19 pandemic. Methods: This retrospective study examined children aged less than 18 years diagnosed with DKA hospitalized in Yazd Shahid Sadoughi Hospital from February 20, 2020, to November 21, 2021. The collected information was compared to those obtained during the same period in 2019 (pre-pandemic). According to the inclusion criteria, only children with suspected symptoms of COVID-19 or an infected family member underwent PCR. Results: The study included 70 children with confirmed DKA during the COVID-19 pandemic and 33 children hospitalized during the pre-pandemic period. The findings showed that the rate of DKA was higher during the pandemic than in the pre-pandemic period. In the DKA subgroups (during the COVID-19 pandemic vs. pre-pandemic), 35.7% vs. 21.2% were severe, 37.1% vs. 36.4% were moderate, and 27.1% vs. 42.4% were mild. Of 70 children, 30 underwent PCR tests for COVID-19, showing six positive cases. Among positive cases, five had mild symptoms, while one was hospitalized with signs of respiratory distress, polyuria, and polydipsia. All physical examinations of this patient were normal, except for the chest exam. Conclusions: A remarkable increase was observed in the frequency and severity of DKA in children during the pandemic.
- Open Access
- 1 January 2023
- Published byĀ WileyĀ inĀ Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol.Ā 2023 Ā (1) , 8838056
Which Groups of Children Are at More Risk of Fatality during COVIDā19 Pandemic? A CaseāControl Study in Yazd, Iran
Introduction. The study aims to investigate the characteristics, comorbidities, laboratory findings, and clinical manifestations of under 18āyearāold patients who died with the diagnosis of COVIDā19 and determination of the most prevalent risk factors. Method. This caseācontrol study was performed at a referral hospital in Yazd from March 2020 to August 2021. All patients under 18 years who were diagnosed through realātime RTāPCR, chest computed tomography, and the World Health Organization definition were divided into deceased and survived groups. The characteristics (age and sex), disease severity, comorbidities, laboratory findings, and clinical manifestations of the two groups were compared and analyzed using SPSS, version 18 (SPSS Inc., Chicago, III., USA). Results. A total of 24 patients in the deceased group and 167 patients in the survived group were compared. The highest mortality rate was observed in the age group of 1 month to 5 years, although no statistically significant relationship was found between age groups and the risk of mortality. Disease severity, dyspnea, low oxygen saturation on admission, length of hospital stays, and hospitalization history before the last admission were significantly correlated with mortality (P < 0.05). Lymphopenia increased the probability of mortality by more than two times (OR: 2.568; 95% CI (0.962ā6.852)), but this was not the case for Dādimer and Cāreactive protein. Furthermore, 27.5% of survived patients had normal chest CT scans, which was a statistically significant difference compared to the deceased patients (P: 0.031). Conclusion. Based on the findings of this study, dyspnea, low oxygen saturation, and lymphopenia are critical indicators for identifying highārisk children with COVIDā19 and triaging them for better care and treatment.
- 1 January 2023
- Published byĀ WileyĀ inĀ Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol.Ā 2023 Ā (1) , 8838056
Open AccessWhich Groups of Children Are at More Risk of Fatality during COVIDā19 Pandemic? A CaseāControl Study in Yazd, Iran
Introduction. The study aims to investigate the characteristics, comorbidities, laboratory findings, and clinical manifestations of under 18āyearāold patients who died with the diagnosis of COVIDā19 and determination of the most prevalent risk factors. Method. This caseācontrol study was performed at a referral hospital in Yazd from March 2020 to August 2021. All patients under 18 years who were diagnosed through realātime RTāPCR, chest computed tomography, and the World Health Organization definition were divided into deceased and survived groups. The characteristics (age and sex), disease severity, comorbidities, laboratory findings, and clinical manifestations of the two groups were compared and analyzed using SPSS, version 18 (SPSS Inc., Chicago, III., USA). Results. A total of 24 patients in the deceased group and 167 patients in the survived group were compared. The highest mortality rate was observed in the age group of 1 month to 5 years, although no statistically significant relationship was found between age groups and the risk of mortality. Disease severity, dyspnea, low oxygen saturation on admission, length of hospital stays, and hospitalization history before the last admission were significantly correlated with mortality (P < 0.05). Lymphopenia increased the probability of mortality by more than two times (OR: 2.568; 95% CI (0.962ā6.852)), but this was not the case for Dādimer and Cāreactive protein. Furthermore, 27.5% of survived patients had normal chest CT scans, which was a statistically significant difference compared to the deceased patients (P: 0.031). Conclusion. Based on the findings of this study, dyspnea, low oxygen saturation, and lymphopenia are critical indicators for identifying highārisk children with COVIDā19 and triaging them for better care and treatment.
- Open Access
- 1 January 2023
- Published byĀ WileyĀ inĀ Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol.Ā 2023 Ā (1) , 5205188
Survival and Mortality in Hospitalized Children with COVIDā19: A Referral Center Experience in Yazd, Iran
Introduction. COVIDā19 prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases are still under investigation. Materials and Methods. This historical cohort study evaluated the survival time of hospitalized children (1 monthā18 years old) with COVIDā19 admitted from March 2020 to August 2021 to an educational hospital in Yazd, Iran. The followāup of patients was performed at least one month after discharge. Results. From 183 hospitalized cases, 24 children were deceased. The median age of patients was 5.41, and 54.2% were male. The survival rate after oneāmonth followāup was 0.88, and the most significant predictors associated with survival time were the male sex, positive history of hospitalization, lymphopenia, hypoxia, and length of stay more than two weeks using Bayesian Cox regression analysis. Conclusion. Accurate estimation of the impact of predictors on poor outcomes may help healthcare providers use therapeutic protocols based on risk factors and healthcare requirements of each patient to improve their survival.
- 1 January 2023
- Published byĀ WileyĀ inĀ Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol.Ā 2023 Ā (1) , 5205188
Open AccessSurvival and Mortality in Hospitalized Children with COVIDā19: A Referral Center Experience in Yazd, Iran
Introduction. COVIDā19 prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases are still under investigation. Materials and Methods. This historical cohort study evaluated the survival time of hospitalized children (1 monthā18 years old) with COVIDā19 admitted from March 2020 to August 2021 to an educational hospital in Yazd, Iran. The followāup of patients was performed at least one month after discharge. Results. From 183 hospitalized cases, 24 children were deceased. The median age of patients was 5.41, and 54.2% were male. The survival rate after oneāmonth followāup was 0.88, and the most significant predictors associated with survival time were the male sex, positive history of hospitalization, lymphopenia, hypoxia, and length of stay more than two weeks using Bayesian Cox regression analysis. Conclusion. Accurate estimation of the impact of predictors on poor outcomes may help healthcare providers use therapeutic protocols based on risk factors and healthcare requirements of each patient to improve their survival.
- 19 October 2021
- Published byĀ Knowledge E DMCCĀ inĀ World Journal of Peri & Neonatology
Association of IRF6 rs2235371 Polymorphism with Non-Syndromic Cleft Lip/Palate: A Meta-analysis
Background: The previous published data on the association between interferon regulatory factor 6 (IRF6) polymorphisms and non-syndromic Cleft Lip/Palate (NSCL ± P) risk remained inconclusive. The aim of this study was to conduct a meta-analysis to further assess the associations. Methods: A comprehensive search in PubMed, EMBASE, Web of Science, and CNKI for all eligible studies up July 2021. Results: A total of 23 studies with 6,161 cases and 8,919 controls were selected for this meta-analysis. Overall pooled analysis suggest a significant association between IRF6 rs2235371 polymorphism and CL±P risk under all the five genetic models, i.e., allele (A vs. G: OR=0.754, 95% CI 0.628-0.905, P=0.002), homozygote (AA vs. GG: OR=0.621 95% 0.405-0.953, P=0.029), heterozygote (AC vs. GG: OR=0.619, 95% CI 0.485-0.791, Pā¤0.001), dominant (AA+AG vs. GG: OR=0.550, 95% CI 0.381-0.794, P=0.001) and recessive model (AA vs. AG+GG: OR=0.583, 95% CI 0.423-0.804, P=0.001). Subgroup analysis by ethnicity showed that rs2235371 was associated with NSCL±P risk in Asians. Conclusion: This meta-analysis provides strong evidences that IRF6 rs2235371 might be associated with risk of NSCL ± P.
- 19 October 2021
- Published byĀ Knowledge E DMCCĀ inĀ World Journal of Peri & Neonatology
Association of IRF6 rs2235371 Polymorphism with Non-Syndromic Cleft Lip/Palate: A Meta-analysis
Background: The previous published data on the association between interferon regulatory factor 6 (IRF6) polymorphisms and non-syndromic Cleft Lip/Palate (NSCL ± P) risk remained inconclusive. The aim of this study was to conduct a meta-analysis to further assess the associations. Methods: A comprehensive search in PubMed, EMBASE, Web of Science, and CNKI for all eligible studies up July 2021. Results: A total of 23 studies with 6,161 cases and 8,919 controls were selected for this meta-analysis. Overall pooled analysis suggest a significant association between IRF6 rs2235371 polymorphism and CL±P risk under all the five genetic models, i.e., allele (A vs. G: OR=0.754, 95% CI 0.628-0.905, P=0.002), homozygote (AA vs. GG: OR=0.621 95% 0.405-0.953, P=0.029), heterozygote (AC vs. GG: OR=0.619, 95% CI 0.485-0.791, Pā¤0.001), dominant (AA+AG vs. GG: OR=0.550, 95% CI 0.381-0.794, P=0.001) and recessive model (AA vs. AG+GG: OR=0.583, 95% CI 0.423-0.804, P=0.001). Subgroup analysis by ethnicity showed that rs2235371 was associated with NSCL±P risk in Asians. Conclusion: This meta-analysis provides strong evidences that IRF6 rs2235371 might be associated with risk of NSCL ± P.
- 17 September 2021
- Published byĀ Springer NatureĀ inĀ Journal of Diabetes & Metabolic Disorders
- Vol.Ā 20 Ā (2) , 2129-2132
New onset of diabetes in a child infected with COVID-19: a case report
Background Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes. A few studies have reported that COVID-19 is associated with the development of new-onset diabetes. Here, we present an infected child with new onset diabetes leading to DKA. Case presentation A 10-year-old patient with respiratory distress admitted to the Emergency Department of our center. The patientās COVID-19 Polymerase Chain Reaction (PCR) test was positive and also biochemical analyses confirmed that he had DKA. Despite standard initial treatments, ketoacidosis remained resistant; hence we prescribed oral bicarbonate (40 cc every 8 h) to treat the patient's refractory acidosis. Due to the patientās improvement, he was discharged after 10 days (7 days in the PICU), receiving outpatient enoxaparin (for a week) and ongoing subcutaneous insulin. Conclusion We report an interesting case of a child with COVID-19 infection precipitating presentation with new onset diabetes. Due to refractory acidosis, starting oral bicarbonate treatment after 2 days improved acidosis and tachypnea in the patient. The patientās medical team suggest close biochemical monitoring, prescribing enoxaparin for high level of D-dimer, and ordering oral bicarbonate acidosis persists.
- 17 September 2021
- Published byĀ Springer NatureĀ inĀ Journal of Diabetes & Metabolic Disorders
- Vol.Ā 20 Ā (2) , 2129-2132
New onset of diabetes in a child infected with COVID-19: a case report
Background Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes. A few studies have reported that COVID-19 is associated with the development of new-onset diabetes. Here, we present an infected child with new onset diabetes leading to DKA. Case presentation A 10-year-old patient with respiratory distress admitted to the Emergency Department of our center. The patientās COVID-19 Polymerase Chain Reaction (PCR) test was positive and also biochemical analyses confirmed that he had DKA. Despite standard initial treatments, ketoacidosis remained resistant; hence we prescribed oral bicarbonate (40 cc every 8 h) to treat the patient's refractory acidosis. Due to the patientās improvement, he was discharged after 10 days (7 days in the PICU), receiving outpatient enoxaparin (for a week) and ongoing subcutaneous insulin. Conclusion We report an interesting case of a child with COVID-19 infection precipitating presentation with new onset diabetes. Due to refractory acidosis, starting oral bicarbonate treatment after 2 days improved acidosis and tachypnea in the patient. The patientās medical team suggest close biochemical monitoring, prescribing enoxaparin for high level of D-dimer, and ordering oral bicarbonate acidosis persists.